Figure 4
From: Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Levels of endogenous prolyl oligopeptidase inhibitor, and its relation with prolyl oligopeptidase activity, in plasma from healthy and RR-MS patients. A. Inhibitory effect of plasma (25 μl) from healthy controls (white bar, n = 17) and RR-MS patients (gray bar, n = 11) on the activity of pure POP (basal activity 100 nmol/min/mg of POP), ***, p-value = 0.0002. B. Relationship between plasma POP activity, and endogenous POP inhibitor content, expressed as % of inhibition of pure POP (data from part A.) in healthy controls (n = 17) and RR-MS patients (n = 11). No statistically significant correlation was found.